Literature DB >> 20197623

Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas.

Ki Taek Nam1, Hyuk-Joon Lee, J Joshua Smith, Lynne A Lapierre, Vidya P Kamath, Xi Chen, Bruce J Aronow, Timothy J Yeatman, Sheela G Bhartur, Benjamin C Calhoun, Brian Condie, Nancy R Manley, R Daniel Beauchamp, Robert J Coffey, James R Goldenring.   

Abstract

Transformation of epithelial cells is associated with loss of cell polarity, which includes alterations in cell morphology as well as changes in the complement of plasma membrane proteins. Rab proteins regulate polarized trafficking to the cell membrane and therefore represent potential regulators of this neoplastic transition. Here we have demonstrated a tumor suppressor function for Rab25 in intestinal neoplasia in both mice and humans. Human colorectal adenocarcinomas exhibited reductions in Rab25 expression independent of stage, with lower Rab25 expression levels correlating with substantially shorter patient survival. In wild-type mice, Rab25 was strongly expressed in cells luminal to the proliferating cells of intestinal crypts. While Rab25-deficient mice did not exhibit gross pathology, ApcMin/+ mice crossed onto a Rab25-deficient background showed a 4-fold increase in intestinal polyps and a 2-fold increase in colonic tumors compared with parental ApcMin/+ mice. Rab25-deficient mice had decreased beta1 integrin staining in the lateral membranes of villus cells, and this pattern was accentuated in Rab25-deficient mice crossed onto the ApcMin/+ background. Additionally, Smad3+/- mice crossed onto a Rab25-deficient background demonstrated a marked increase in colonic tumor formation. Taken together, these results suggest that Rab25 may function as a tumor suppressor in intestinal epithelial cells through regulation of protein trafficking to the cell surface.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20197623      PMCID: PMC2827957          DOI: 10.1172/JCI40728

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

Review 1.  Pathology of mouse models of intestinal cancer: consensus report and recommendations.

Authors:  Gregory P Boivin; Kay Washington; Kan Yang; Jerrold M Ward; Theresa P Pretlow; Robert Russell; David G Besselsen; Virginia L Godfrey; Tom Doetschman; William F Dove; Henry C Pitot; Richard B Halberg; Steven H Itzkowitz; Joanna Groden; Robert J Coffey
Journal:  Gastroenterology       Date:  2003-03       Impact factor: 22.682

2.  Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments.

Authors:  Patrick T Caswell; Heather J Spence; Maddy Parsons; Dominic P White; Katherine Clark; Kwai Wa Cheng; Gordon B Mills; Martin J Humphries; Anthea J Messent; Kurt I Anderson; Mary W McCaffrey; Bradford W Ozanne; Jim C Norman
Journal:  Dev Cell       Date:  2007-10       Impact factor: 12.270

3.  Identification of a small GTP-binding protein, Rab25, expressed in the gastrointestinal mucosa, kidney, and lung.

Authors:  J R Goldenring; K R Shen; H D Vaughan; I M Modlin
Journal:  J Biol Chem       Date:  1993-09-05       Impact factor: 5.157

4.  Identification and characterization of a family of Rab11-interacting proteins.

Authors:  C M Hales; R Griner; K C Hobdy-Henderson; M C Dorn; D Hardy; R Kumar; J Navarre; E K Chan; L A Lapierre; J R Goldenring
Journal:  J Biol Chem       Date:  2001-08-08       Impact factor: 5.157

5.  The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers.

Authors:  Kwai Wa Cheng; John P Lahad; Wen-Lin Kuo; Anna Lapuk; Kyosuke Yamada; Nelly Auersperg; Jinsong Liu; Karen Smith-McCune; Karen H Lu; David Fishman; Joe W Gray; Gordon B Mills
Journal:  Nat Med       Date:  2004-10-24       Impact factor: 53.440

6.  Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis.

Authors:  S J Engle; J B Hoying; G P Boivin; I Ormsby; P S Gartside; T Doetschman
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

7.  Regulation of vesicle trafficking in madin-darby canine kidney cells by Rab11a and Rab25.

Authors:  X Wang; R Kumar; J Navarre; J E Casanova; J R Goldenring
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

8.  Identification and characterization of the familial adenomatous polyposis coli gene.

Authors:  J Groden; A Thliveris; W Samowitz; M Carlson; L Gelbert; H Albertsen; G Joslyn; J Stevens; L Spirio; M Robertson
Journal:  Cell       Date:  1991-08-09       Impact factor: 41.582

9.  Conditional deletion of beta1 integrins in the intestinal epithelium causes a loss of Hedgehog expression, intestinal hyperplasia, and early postnatal lethality.

Authors:  Robert G Jones; Xiufen Li; Phillip D Gray; Jinqiu Kuang; Frederic Clayton; Wade S Samowitz; Blair B Madison; Deborah L Gumucio; Scott K Kuwada
Journal:  J Cell Biol       Date:  2006-11-06       Impact factor: 10.539

10.  Improved human disease candidate gene prioritization using mouse phenotype.

Authors:  Jing Chen; Huan Xu; Bruce J Aronow; Anil G Jegga
Journal:  BMC Bioinformatics       Date:  2007-10-16       Impact factor: 3.169

View more
  78 in total

1.  Inactivation of MYO5B promotes invasion and motility in gastric cancer cells.

Authors:  Wenjie Dong; Xiaobing Chen; Ping Chen; Dongli Yue; Linan Zhu; Qingxia Fan
Journal:  Dig Dis Sci       Date:  2011-12-02       Impact factor: 3.199

Review 2.  The role of endocytic Rab GTPases in regulation of growth factor signaling and the migration and invasion of tumor cells.

Authors:  N Porther; M A Barbieri
Journal:  Small GTPases       Date:  2015-08-20

3.  Recycling Endosomes in Mature Epithelia Restrain Tumorigenic Signaling.

Authors:  Luca D'Agostino; Yingchao Nie; Sayantani Goswami; Kevin Tong; Shiyan Yu; Sheila Bandyopadhyay; Juan Flores; Xiao Zhang; Iyshwarya Balasubramanian; Ivor Joseph; Ryotaro Sakamori; Victoria Farrell; Qi Li; Chung S Yang; Bin Gao; Ronaldo P Ferraris; Ghassan Yehia; Edward M Bonder; James R Goldenring; Michael P Verzi; Lanjing Zhang; Y Tony Ip; Nan Gao
Journal:  Cancer Res       Date:  2019-06-25       Impact factor: 12.701

4.  Novel candidates in early-onset familial colorectal cancer.

Authors:  Anne M L Jansen; Pradipta Ghosh; Tikam C Dakal; Thomas P Slavin; C Richard Boland; Ajay Goel
Journal:  Fam Cancer       Date:  2019-09-25       Impact factor: 2.375

Review 5.  Animal models of human genetic diseases: do they need to be faithful to be useful?

Authors:  Jean-Louis Guénet
Journal:  Mol Genet Genomics       Date:  2011-05-06       Impact factor: 3.291

Review 6.  Pathology of rodent models of intestinal cancer: progress report and recommendations.

Authors:  Mary Kay Washington; Anne E Powell; Ruth Sullivan; John P Sundberg; Nicholas Wright; Robert J Coffey; William F Dove
Journal:  Gastroenterology       Date:  2013-02-12       Impact factor: 22.682

Review 7.  Rab GTPases, membrane trafficking and diseases.

Authors:  Guangpu Li
Journal:  Curr Drug Targets       Date:  2011-07-01       Impact factor: 3.465

8.  Orphan Gpr182 suppresses ERK-mediated intestinal proliferation during regeneration and adenoma formation.

Authors:  Daniel O Kechele; R Eric Blue; Bailey Zwarycz; Scott T Espenschied; Amanda T Mah; Marni B Siegel; Charles M Perou; Shengli Ding; Scott T Magness; P Kay Lund; Kathleen M Caron
Journal:  J Clin Invest       Date:  2017-01-17       Impact factor: 14.808

9.  Rab25 is overexpressed in Müllerian serous carcinoma compared to malignant mesothelioma.

Authors:  Kjersti Brusegard; Helene Tuft Stavnes; Dag André Nymoen; Kjersti Flatmark; Claes G Trope; Ben Davidson
Journal:  Virchows Arch       Date:  2012-01-17       Impact factor: 4.064

Review 10.  The dual functions of Rab11 and Rab35 GTPases-regulation of cell division and promotion of tumorigenicity.

Authors:  Paulius Gibieža; Vilma Petrikaitė
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.